Search
Search Results
Found 13 items.
-
Cancer complicated by thrombosis and thrombocytopenia: still a therapeutic dilemma
Published: 16 May 2024251PDF: 84 -
Identifying novel biomarkers using proteomics to predict cancer-associated thrombosis
Published: 16 May 2024416PDF: 170 -
New drugs, old problems: immune checkpoint inhibitors and cancer-associated thrombosis
Published: 16 May 2024236PDF: 118 -
Machine learning in cancer-associated thrombosis: hype or hope in untangling the clot
Published: 16 May 2024655PDF: 91 -
Factor XI inhibitors: a new option for the prevention and treatment of cancer-associated thrombosis
Published: 16 May 2024325PDF: 137 -
Patient and public involvement in cancer-associated thrombosis research: necessary or glorified tokenism?
Published: 16 May 2024950PDF: 93 -
Trends and updates on the epidemiology of cancer-associated thrombosis: a systematic review
Published: 16 May 2024393PDF: 126 -
Venous thromboembolism treatment in patients with cancer: reflections on an evolving landscape
Published: 29 February 20241190PDF: 180 -
Location of metastasis and complications in patients with venous thromboembolism and cancer: systematic review
Published: 16 May 2024232PDF: 79 -
Coagulome and tumor microenvironment: impact of oncogenes, cellular heterogeneity and extracellular vesicles
Published: 16 May 2024224PDF: 97 -
-
Risk of recurrent venous thromboembolism in cancer patients after discontinuation of anticoagulant therapy
Published: 16 May 2024214PDF: 121 -
Endothelial cell dysfunction in cancer: a not-so-innocent bystander
Published: 16 May 2024826PDF: 100
1 - 13 of 13 items